Nutritional aspects of inflammatory bowel disease

References

• Day AS, Lemberg DA. Identification and diagnosis of Crohn disease and ulcerative colitis in children. J Paediatr Child Health. 2020;56(11):1731–1734. doi: 10.1111/jpc.14925
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, et al. Inflammatory bowel disease: estimates from the global burden of disease 2017 study. Aliment Pharmacol Ther. 2020;51(2):261–270. doi: 10.1111/apt.15542
   PubMed Web of Science ®Google Scholar
• Mentella MC, Scaldaferri F, Pizzoferrato M, et al. Nutrition, IBD and gut microbiota: a review. Nutrients. 2020;12(4):9442. doi: 10.3390/nu12040944
   Web of Science ®Google Scholar
• Seyed Tabib NS, Madgwick M, Sudhakar P, et al. Big data in IBD: big progress for clinical practice. Gut. 2020;69(8):1520–1532. doi: 10.1136/gutjnl-2019-320065
   PubMed Web of Science ®Google Scholar
• Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21(8):40. doi: 10.1007/s11894-019-0705-6
   PubMedGoogle Scholar
• Fiorino G, Estevinho MM, Lopes DJM, et al. Inflammatory bowel disease in migrant populations: should we look even further back? Curr Drug Targets. 2021 4;22(15):1706–1715. doi: 10.2174/1389450122666210203193817
   PubMed Web of Science ®Google Scholar
• Ansari I, Raddatz G, Gutekunst J, et al. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat Microbiol. 2020;5(4):610–619. doi: 10.1038/s41564-019-0659-3
   PubMed Web of Science ®Google Scholar
• Hattori N, Niwa T, Ishida T, et al. Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis model. Cancer Sci. 2019;110(1):147–156. doi: 10.1111/cas.13880
   PubMed Web of Science ®Google Scholar
• Lepage P, Hösler R, Spehlmann ME, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology. 2011;141(1):227–236. doi: 10.1053/j.gastro.2011.04.011
   PubMed Web of Science ®Google Scholar
• Lupp C, Robertson ML, Wickham ME, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe. 2007;2(2):119–129. doi: 10.1016/j.chom.2007.06.010
   PubMed Web of Science ®Google Scholar
• Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):179–184. doi: 10.1002/ibd.21339
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–392. doi: 10.1016/j.chom.2014.02.005
   PubMed Web of Science ®Google Scholar
• Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1–10. doi: 10.1007/s12328-017-0813-5
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55(2):205–211. doi: 10.1136/gut.2005.073817
   PubMed Web of Science ®Google Scholar
• Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis. 2009;15(5):653–660. doi: 10.1002/ibd.20783
   PubMed Web of Science ®Google Scholar
• Adolph TE, Zhang J. Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. Gut. 2022;71(12):2574–2586. doi: 10.1136/gutjnl-2021-326575
   PubMed Web of Science ®Google Scholar
• Schwärzler J, Mayr L, Vich Vila A, et al. PUFA-Induced metabolic enteritis as a fuel for crohn’s disease. Gastroenterology. 2022;162(6):1690–1704. doi: 10.1053/j.gastro.2022.01.004
   PubMed Web of Science ®Google Scholar
• Khalili H, Chan SSM, Lochhead P, et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2019;15(9):525–535. doi: 10.1038/s41575-018-0022-9
   Web of Science ®Google Scholar
• Raoul P, Cintoni M, Palombaro M, et al. Food additives, a key environmental factor in the development of IBD through gut dysbiosis. Microorganisms. 2022;10(1):167. doi: 10.3390/microorganisms10010167
   PubMed Web of Science ®Google Scholar
• Ahmad SY, Friel J, Mackay D. The effects of non-nutritive artificial sweeteners, aspartame and sucralose, on the gut microbiome in healthy adults: secondary outcomes of a randomized double-blinded crossover clinical trial. Nutrients. 2020;12(11):3408. doi: 10.3390/nu12113408
   PubMed Web of Science ®Google Scholar
• Serrano J, Smith KR, Crouch AL, et al. High-dose saccharin supplementation does not induce gut microbiota changes or glucose intolerance in healthy humans and mice. Microbiome. 2021;9(1):11. doi: 10.1186/s40168-020-00976-w
   PubMed Web of Science ®Google Scholar
• Zhao M, Cai H, Jiang Z, et al. Glycerol-monolaurate-mediated attenuation of metabolic syndrome is associated with the modulation of gut microbiota in high-fat-diet-fed mice. Mol Nutr Food Res. 2019;63(18):e1801417. doi: 10.1002/mnfr.201801417
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu H, Wang Q, et al. Dietary additive octyl and decyl glycerate modulates metabolism and inflammation under different dietary patterns with the contribution of the gut microbiota Food Funct. Food Funct. 2023;14(1):525–540. doi: 10.1039/D2FO03059D
   PubMed Web of Science ®Google Scholar
• Zhao M, Jiang Z, Cai H, et al. Modulation of the gut microbiota during high-dose glycerol monolaurate-mediated amelioration of obesity in mice fed a high-fat diet. MBio. 2020;11(2):e00190–20. doi: 10.1128/mBio.00190-20
   PubMed Web of Science ®Google Scholar
• He Z, Chen L, Catalan-Dibene J, et al. Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23. Cell Metab. 2021;33(7):1358–1371.e5. doi: 10.1016/j.cmet.2021.04.015
   PubMed Web of Science ®Google Scholar
• Vasseur P, Dugelay E, Benamouzig R, et al. Dietary patterns, ultra-processed food, and the risk of inflammatory bowel diseases in the nutrinet-santé cohort. Inflamm Bowel Dis. 2021;27(1):65–73. doi: 10.1093/ibd/izaa018
   PubMed Web of Science ®Google Scholar
• Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;14(374):n1554. doi: 10.1136/bmj.n1554
   Google Scholar
• Lo C-H, Khandpur N, Rossato SL, et al. Ultra-processed foods and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2022;20(6):e1323–37. doi: 10.1016/j.cgh.2021.08.031
   PubMed Web of Science ®Google Scholar
• De Silva PSA, Luben R, Shrestha SS, et al. Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries. Eur J Gastroenterol Hepatol. 2014;26(1):11–18. doi: 10.1097/MEG.0b013e328365c372
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut. 2014;63(5):776–784. doi: 10.1136/gutjnl-2013-305304
   PubMed Web of Science ®Google Scholar
• Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563–573. doi: 10.1038/ajg.2011.44
   PubMed Web of Science ®Google Scholar
• Mozaffari H, Daneshzad E, Larijani B, et al. Dietary intake of fish, n-3 polyunsaturated fatty acids, and risk of inflammatory bowel disease: a systematic review and meta-analysis of observational studies. Eur J Nutr. 2020;59(1):1–17. doi: 10.1007/s00394-019-01901-0
   PubMed Web of Science ®Google Scholar
• Mayr L, Grabherr F, Schwärzler J, et al. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease. Nat Commun. 2020;11(1):1775. doi: 10.1038/s41467-020-15646-6
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53(10):1479–1484. doi: 10.1136/gut.2003.024828
   PubMed Web of Science ®Google Scholar
• Jantchou P, Morois S, Clavel-Chapelon F, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105(10):2195–2201. doi: 10.1038/ajg.2010.192
   PubMed Web of Science ®Google Scholar
• Peters V, Bolte L, Schuttert E, et al. Western and carnivorous dietary patterns are associated with greater likelihood of IBD development in a large prospective population-based cohort. J Crohn’s Colitis. 2022;16(6):931–939. doi: 10.1093/ecco-jcc/jjab219
   Google Scholar
• Dong C, Chan SSM, Jantchou P, et al. Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study. J Crohns Colitis. 2022;16(8):1187–1196. doi: 10.1093/ecco-jcc/jjac054
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145(5):970–977. doi: 10.1053/j.gastro.2013.07.050
   PubMed Web of Science ®Google Scholar
• Amre DK, D’Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for crohn’s disease in children. Am J Gastroenterol. 2007;102(9):2016–2025. doi: 10.1111/j.1572-0241.2007.01411.x
   PubMed Web of Science ®Google Scholar
• Yu X, Zuo T. Editorial: food additives, cooking and processing: impact on the microbiome. Front Nutr. 2021;8:731040. doi: 10.3389/fnut.2021.731040
   PubMed Web of Science ®Google Scholar
• Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152(2):398–414.e6. doi: 10.1053/j.gastro.2016.10.019
   PubMed Web of Science ®Google Scholar
• Pfeffer-Gik T, Levine A. Dietary clues to the pathogenesis of Crohn’s disease. Dig Dis. 2014;32(4):389–394. doi: 10.1159/000358143
   PubMed Web of Science ®Google Scholar
• Martino JV, Van Limbergen J, Cahill LE. The role of carrageenan and carboxymethylcellulose in the development of intestinal inflammation. Front Pediatr. 2017;5:96. doi: 10.3389/fped.2017.00096
   PubMed Web of Science ®Google Scholar
• Watt J, Marcus R. Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut. 1971;12(2):164–171. doi: 10.1136/gut.12.2.164
   PubMed Web of Science ®Google Scholar
• Noa M, Mas R. Effect of D-002 on the pre-ulcerative phase of carrageenan-induced colonic ulceration in the guinea-pig. J Pharm Pharmacol. 1998;50(5):549–553. doi: 10.1111/j.2042-7158.1998.tb06197.x
   PubMed Web of Science ®Google Scholar
• Anver MR, Cohen J. Animal model of human disease. Ulcerative colitis. Animal model: ulcerative colitis induced in guinea pigs with degraded carrageenan. Am J Pathol. 1976;84(2):431–434.
   PubMedGoogle Scholar
• Raphael W, Sordillo LM. Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis. Intern J Mol Sci. 2013;14(10):21167–21188. doi: 10.3390/ijms141021167
   PubMed Web of Science ®Google Scholar
• Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754–760. doi: 10.1136/gut.40.6.754
   PubMed Web of Science ®Google Scholar
• Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseases: the established and the new. World J Gastroenterol. 2016;22(7):2179–2194. doi: 10.3748/wjg.v22.i7.2179
   PubMed Web of Science ®Google Scholar
• Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(2):154–163. doi: 10.1097/00054725-200502000-00009
   PubMed Web of Science ®Google Scholar
• Octoratou M, Merikas E, Malgarinos G, et al. A prospective study of pre-illness diet in newly diagnosed patients with Crohn’s disease. Rev Med Chir Soc Med Nat Iasi. 2012;116(1):40–49.
   PubMedGoogle Scholar
• Parada Venegas D, La Fuente MK D, Landskron G, et al. Short chain fatty acids (SCFAs) mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277. doi: 10.3389/fimmu.2019.00277
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Garge N, Zhang X, et al. Microbiome, the regulate, butyrate metabolism, energy. Cell Metab. 2011;13(5):517–526. doi: 10.1016/j.cmet.2011.02.018
   PubMed Web of Science ®Google Scholar
• Lin A, Micic D. Nutrition considerations in inflammatory bowel disease. Nutr Clin Prac. 2021;36:298–311. doi: 10.1002/ncp.10628
   PubMed Web of Science ®Google Scholar
• Russell LA, Balart MT, Serrano P, et al. The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions. Nutr Rev. 2022;80(2):215–229. doi: 10.1093/nutrit/nuab015
   PubMed Web of Science ®Google Scholar
• Ciocîrlan M, Ciocîrlan M, Iacob R, et al. Malnutrition prevalence in newly diagnosed patients with inflammatory bowel disease – Data from the national Romanian database. J Gastrointest Liver Dis. 2019;28(2):163–168. doi: 10.15403/jgld-176
   PubMed Web of Science ®Google Scholar
• Weisshof R, Chermesh I. Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metabol Care. 201(18):576–581. 10.1097/MCO.0000000000000226
   Google Scholar
• Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6(3):62–72. doi: 10.4291/wjgp.v6.i3.62
   PubMedGoogle Scholar
• Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. doi: 10.3390/ijms22126493
   PubMed Web of Science ®Google Scholar
• Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohn’s Colitis. 2015;9(3):211–222. doi: 10.1093/ecco-jcc/jju009
   Google Scholar
• López-Muñoz P, Beltrán B, Sáez-González E, et al. Influence of vitamin D deficiency on inflammatory markers and clinical disease activity in IBD patients. Nutrients. 2019;11(5):1059. doi: 10.3390/nu11051059
   PubMed Web of Science ®Google Scholar
• Rufo PA, Denson LA, Sylvester FA, et al. Health supervision in the management of children and adolescents with IBD: nASPGHAN recommendations. J Pediatr Gastroenterol Nutr. 2012;55(1):93–108. doi: 10.1097/MPG.0b013e31825959b8
   PubMed Web of Science ®Google Scholar
• Urena-Torres P, Souberbielle JC. Pharmacologic role of vitamin D natural products. Curr Vasc Pharmacol. 2014;12(2):278–285. doi: 10.2174/15701611113119990020
   PubMed Web of Science ®Google Scholar
• Leslie WD, Miller N, Rogala L, et al. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD cohort study. Am J Gastroenterol. 2008;103(6):1451–1459. doi: 10.1111/j.1572-0241.2007.01753.x
   PubMed Web of Science ®Google Scholar
• Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006;92(1):60–64. doi: 10.1016/j.pbiomolbio.2006.02.020
   PubMed Web of Science ®Google Scholar
• Wöbke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol. 2014;5:1–20. doi: 10.3389/fphys.2014.00244
   PubMed Web of Science ®Google Scholar
• Froicu M, Weaver V, Wynn TA, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17(12):2386–2392. doi: 10.1210/me.2003-0281
   PubMed Web of Science ®Google Scholar
• Raftery T, Martineau AR, Greiller CL, et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: results from a randomised double-blind placebo-controlled study. United Eur Gastroenterol J. 2015;3(3):294–302. doi: 10.1177/2050640615572176
   PubMed Web of Science ®Google Scholar
• Stio M, Retico L, Annese V, et al. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis. Scand J Gastroenterol. 2016;51(10):1193–1199. doi: 10.1080/00365521.2016.1185463
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015;37(1):47–55. doi: 10.1007/s00281-014-0454-4
   PubMed Web of Science ®Google Scholar
• Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39(2):125–136. doi: 10.1111/apt.12553
   PubMed Web of Science ®Google Scholar
• Turner D, Levine A, Walters TD, et al. Which PCDAI version best reflects intestinal inflammation in pediatric Crohn disease? J Pediatr Gastroenterol Nutr. 2017;64(2):254–260. doi: 10.1097/MPG.0000000000001227
   PubMed Web of Science ®Google Scholar
• Filippi J, Al-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn’s disease in remission. Inflamm Bowel Dis. 2006;12(3):185–191. doi: 10.1097/01.MIB.0000206541.15963.c3
   PubMed Web of Science ®Google Scholar
• Battat R, Kopylov U, Szilagyi A, et al. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis. 2014;20:1120–1128. doi: 10.1097/MIB.0000000000000024
   PubMed Web of Science ®Google Scholar
• Coull DB, Tait RC, Anderson JH, et al. Vitamin B12 deficiency following restorative proctocolectomy. Color Dis. 2007 Jul;9(6):562–566. doi: 10.1111/j.1463-1318.2007.01117.x
   PubMed Web of Science ®Google Scholar
• Bermejo F, Algaba A, Guerra I, et al. Should we monitor vitamin B12 and folate levels in Crohn’s disease patients? Scand J Gastroenterol. 2013;48(11):1272–1277. doi: 10.3109/00365521.2013.836752
   PubMed Web of Science ®Google Scholar
• Pan Y, Liu Y, Guo H, et al. Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis. Nutrients. 2017;9(4):382. doi: 10.3390/nu9040382
   PubMed Web of Science ®Google Scholar
• Erkelens MN, Mebius RE. Retinoic acid and immune homeostasis: a balancing act. Trends Immunol. 2017;38(3):168–180. doi: 10.1016/j.it.2016.12.006
   PubMed Web of Science ®Google Scholar
• Ghishan FK, Kiela PR. Vitamins and minerals in inflammatory bowel disease. Gastroenterol Clinic North America. 2017;36:797–808. doi: 10.1016/j.gtc.2017.08.011
   Google Scholar
• Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, et al. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep. 2014;4(1):4768. doi: 10.1038/srep04768
   PubMedGoogle Scholar
• Capozzi A, Scambia G, Lello S. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020;140:55–63. doi: 10.1016/j.maturitas.2020.05.020
   PubMed Web of Science ®Google Scholar
• Skrajnowska D, Bobrowska-Korczak B. Role of zinc in immune system and anti-cancer defense mechanisms. Nutrients. 2019;11(10):2273. doi: 10.3390/nu11102273
   PubMed Web of Science ®Google Scholar
• Vagianos K, Bector S, McConnell J, et al. Nutrition assessment of patients with inflammatory bowel disease. J Parenter Enter Nutr. 2007;31(4):311–319. doi: 10.1177/0148607107031004311
   PubMed Web of Science ®Google Scholar
• Siva S, Rubin DT, Gulotta G, et al. Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(1):152–157. doi: 10.1097/MIB.0000000000000989
   PubMed Web of Science ®Google Scholar